Ascites

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Soung Won Jeong

Abstract

Ascites is the most common cause of decompensation in cirrhosis, and 5% to 10% of patients with compensated cirrhosis develop ascites each year. The main factor of ascites formation is renal sodium retention due to activation of the renin-angiotensin-aldosterone system and sympathetic nervous system by the reduced effective volume secondary to splanchnic arterial vasodilation. Diagnostic paracentesis is indicated in all patients with a new onset of grade 2 or 3 ascites and in those admitted to hospital for any complication of cirrhosis. A serum-ascites albumin gradient of ≥1.1 g/dL indicates portal hypertension with an accuracy of approximately 97%. Sodium restriction, diuretics, and large volume paracentesis are the mainstay of treatment in grade 1 to 3 ascites. The refractoriness of ascites is associated with a poor prognosis with a median survival of approximately six months. Repeated large volume paracentesis plus albumin is the first line treatment, and liver transplantation is recommended in patients with refractory ascites. A careful selection of patients is also important to obtain the beneficial effects of transjugular intrahepatic portosystemic shunts in refractory ascites. This review details the recent diagnosis and...Continue Reading

References

Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R W SchrierJ Rodés
Nov 1, 1988·Gastroenterology·B A RunyonE A Akriviadis
Jan 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P GinésC Rozman
Feb 1, 1994·Seminars in Liver Disease·M BernardiG Gasbarrini
Feb 3, 1994·The New England Journal of Medicine·B A Runyon
Jan 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V ArroyoJ Schölmerich
Aug 1, 1997·Digestive Diseases and Sciences·A GraziottoM Salvagnini
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A L GerbesM Reiser
Apr 17, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M BorzioA Sangiovanni
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kevin P MooreVicente Arroyo
Feb 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Joan ClàriaVicente Arroyo
Jan 20, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Richard MoreauZéra Tellier
Aug 1, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Angelo LucaJaime Bosch
Feb 23, 2008·Seminars in Liver Disease·François Durand, Dominique Valla
May 18, 2010·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver
Jan 13, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mevlut Kurt
Nov 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mauro BernardiMahlon M Wilkes
May 9, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Filippo MorandoPaolo Angeli
Apr 29, 2015·Journal of Hepatology·Christian TrautweinMassimo Pinzani
May 20, 2015·Gastroenterology·Tilman SauerbruchUNKNOWN German Study Group for Prophylaxis of Variceal Rebleeding
Jul 29, 2016·European Journal of Gastroenterology & Hepatology·Asem A ElfertSherief Abd-Elsalam
Mar 21, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Elsa SolàPere Ginès
Apr 15, 2018·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

The Medical Clinics of North America
Wei Hou, Arun J Sanyal
Clinics in Liver Disease
Bimaljit Singh Sandhu, Arun J Sanyal
Gastroenterología y hepatología
Javier Martínez, Agustín Albillos
Postgraduate Medicine
K S Habeeb, J L Herrera
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
J ShaoDai-Ming Fan
© 2022 Meta ULC. All rights reserved